SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: NEWS RELEASEystar Bio-Pharmaceutical Reports First Quarter 2011 Results
[NEWS RELEASEystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million XIAN, CHINA May 23, 2011 --Skystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ( First Quarter 2011 Highlights Revenuereases 46% YoY to $7.0 million Veterinary vaccines totaled $0.3 million, up 30% YoY]